Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 8
Submit an article Journal homepage
72
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Phase I Clinical Trial of Topotecan and Pegylated Liposomal Doxorubicin

Agustin A. Garcia Division of Medical Oncology, University of Southern California Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA
, M.D.,
Lynda Roman Division of Gynecology Oncology, University of Southern California Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA
, M.D.,
Laila Muderspach Division of Gynecology Oncology, University of Southern California Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA
, M.D.,
Anne O'Meara Division of Gynecology Oncology, University of Southern California Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA
, M.D.,
Grace Facio Division of Gynecology Oncology, University of Southern California Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA
, R.N.,
Susan Edwards Division of Medical Oncology, University of Southern California Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA
, R.N. &
Alexander Burnett Division of Gynecology Oncology, University of Southern California Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA
, M.D. show all
Pages 665-670 | Published online: 11 Jun 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Matteo Morotti, Mario Valenzano Menada, Pier Luigi Venturini & Simone Ferrero. (2011) Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment. Expert Opinion on Drug Metabolism & Toxicology 7:6, pages 707-720.
Read now
Gabriella Ferrandina, Giacomo Corrado, Angelo Licameli, Domenica Lorusso, Gilda Fuoco, Salvatore Pisconti & Giovanni Scambia. (2010) Pegylated liposomal doxorubicin in the management of ovarian cancer. Therapeutics and Clinical Risk Management 6, pages 463-483.
Read now
Robert Strother & Daniela Matei. (2009) Pegylated liposomal doxorubicin in ovarian cancer. Therapeutics and Clinical Risk Management 5, pages 639-650.
Read now
Janos Nadas & Duxin Sun. (2006) Anthracyclines as effective anticancer drugs. Expert Opinion on Drug Discovery 1:6, pages 549-568.
Read now

Articles from other publishers (8)

Vinu Krishnan, Vimisha Dharamdasani, Shirin Bakre, Ved Dhole, Debra Wu, Bogdan Budnik & Samir Mitragotri. (2022) Hyaluronic Acid Nanoparticles for Immunogenic Chemotherapy of Leukemia and T-Cell Lymphoma. Pharmaceutics 14:2, pages 466.
Crossref
T. Pullaiah & V. Raveendran. 2020. Camptothecin and Camptothecin Producing Plants. Camptothecin and Camptothecin Producing Plants 47 103 .
Mahdi Karimi, Amir Ghasemi, Parham Sahandi Zangabad, Reza Rahighi, S. Masoud Moosavi Basri, H. Mirshekari, M. Amiri, Z. Shafaei Pishabad, A. Aslani, M. Bozorgomid, D. Ghosh, A. Beyzavi, A. Vaseghi, A. R. Aref, L. Haghani, S. Bahrami & Michael R. Hamblin. (2016) Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chemical Society Reviews 45:5, pages 1457-1501.
Crossref
Kathryn M. Camacho, Sunny Kumar, Stefano Menegatti, Douglas R. Vogus, Aaron C. Anselmo & Samir Mitragotri. (2015) Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid. Journal of Controlled Release 210, pages 198-207.
Crossref
Riccardo Soffietti, Elisa Trevisan & Roberta Rudà. 2014. Neurologic Aspects of Systemic Disease Part III. Neurologic Aspects of Systemic Disease Part III 1199 1218 .
Gabriella FerrandinaMarco PetrilloAngelo LicameliGilda FuocoGiovanni ScambiaGiacomo Corrado. (2017) Pegylated Liposomal Doxorubicin in the Management of Ovarian Cancer. Clinical Medicine Insights: Therapeutics 2, pages CMT.S4456.
Crossref
Peter G. Rose, Mary Smrekar, Pam Haba, Nancy Fusco & Michael Rodriguez. (2008) A Phase I Study of Oral Topotecan and Pegylated Liposomal Doxorubicin (Doxil) in Platinum-Resistant Ovarian and Peritoneal Cancer. American Journal of Clinical Oncology 31:5, pages 476-480.
Crossref
Jenifer M. Saucier, Jiang Yu, Anjali Gaikwad, Robert L. Coleman, Judith K. Wolf & Judith A. Smith. (2016) Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model. Journal of Oncology Pharmacy Practice 13:1, pages 39-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.